๐ Treatment with convalescent plasma for critically ill patients with SARS-CoV-2 infection.
As of March 24, 2020, novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been responsible for 379,661 infection cases with 16,428 deaths globally and the number is still increasing rapidly. Herein, we presented four critically ill patients with SARS-CoV-2 infection who received supportive care and convalescent plasma. Although all the four patients (including a pregnant woman) recovered from SARS-CoV-2 infection eventually, randomized trials are needed to eliminate the effect of other treatments and investigate the safety and efficacy of convalescent plasma therapy.
keywords
๐ Convalescent plasma (22)
๐ Critically illness ()
๐ SARS-CoV-2 (551)
๐ severe acute (1373)
๐ syndrome coronavirus (1074)
๐ convalescent plasma (22)
๐ respiratory syndrome (2004)
๐ acute respiratory (1734)
author
๐ค Zhang, Bin
๐ค Liu, Shuyi
๐ค Tan, Tan
๐ค Huang, Wenhui
๐ค Dong, Yuhao
๐ค Chen, Luyan
๐ค Chen, Qiuying
๐ค Zhang, Lu
๐ค Zhong, Qingyang
๐ค Zhang, Xiaoping
๐ค Zou, Yujian
๐ค Zhang, Shuixing
year
โฐ 2020
journal
๐ Chest
issn
๐
volume
number
page
citedbycount
0
download
๐ [BibTeX]